打破免疫覆盖停滞:在中东和北非地区主流化未充分利用的免疫策略
中东和北非地区许多中等收入国家免疫覆盖率近年停滞,政治经济动荡是促因。本文回顾了三种未充分利用策略的国家经验:识别并纳入流离失所、流动和忽视人群;评估并解决免疫接种错过机会,包括将免疫服务扩展至第二生命年及以后;与私立/非政府卫生提供者有效合作协调、提供和报告免疫服务。数据有限,但有证据表明每种策略可对免疫覆盖率产生积极影响,尤其在边缘化人群中。
要点
- 识别并纳入流离失所、流动和忽视人群可提升免疫覆盖率。
- 评估并解决免疫接种错过机会,扩展免疫至第二生命年及以后。
- 与私立/非政府卫生提供者有效合作协调、提供和报告免疫服务。
核心结论
- 来自中等收入国家的证据表明,三种未充分利用的策略均可对免疫覆盖率产生积极影响,尤其在边缘化人群中,但数据有限。
研究设计与样本
- 本文回顾了中等收入国家,特别是联合国儿童基金会中东和北非地区国家,在三种未充分利用的免疫策略方面的国家经验。
主要发现
- 政治和经济动荡是许多中等收入国家免疫覆盖率停滞的促因。
- 三种未充分利用的策略包括:识别并纳入流离失所、流动和忽视人群;评估并解决免疫接种错过机会,包括将免疫服务扩展至第二生命年及以后;与私立/非政府卫生提供者有效合作协调、提供和报告免疫服务。
- 示例主要聚焦于策略中高质量数据收集、分析、使用和报告方面。
- 数据有限,但有证据表明每种策略可对免疫覆盖率产生积极影响,尤其在边缘化人群中。
局限性
- 数据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vaccination coverage rates have stagnated in the past several years in many middle-income countries (MICs), especially in the UNICEF Middle East and North Africa region, with political and economic turmoil as contributing factors. This paper reviews country experiences with three under-utilized strategies aimed at increasing vaccination coverage and reducing disparities between socio-economic and geographic groups in MICs. These strategies include: (1) identifying and accounting for displaced, mobile and neglected populations; (2) assessing and addressing missed opportunities for vaccination, including by expanding immunization into the second year of life and beyond; and (3) engaging effectively with the private/nongovernmental health providers in the coordination, provision and reporting of immunization services. The examples focus primarily on quality data collection, analysis, use and reporting aspects of the strategies. While data are limited, there is evidence from MICs that each of these strategies can have a positive impact on vaccination coverage, especially among marginalized populations.
引用
- Sadr-Azodi N, DeRoeck D, Senouci K, et al. Breaking the inertia in coverage: Mainstreaming under-utilized immunization strategies in the Middle East and North Africa region. Vaccine. 2018. PMID: 29859804. doi:10.1016/j.vaccine.2018.05.088
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。